Thesis
Treatment outcome of combination therapy of Pegylated interferon-α2a, Sofosbuvir and Ribavirin for 12 weeks versus combination of Sofosbuvir and Ribavirin for 24 weeks in HCV Genotype 3 chronic hepatitis and compensated cirrhosis patients
Course: FCPS, Guide: Prof. Salimur Rahman
No other version available